BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Policy

  Pfizer Scientist: Elizabeth Holmes, Theranos Used Company Logo Without Permission

  The ongoing criminal trial of Holmes revealed Elizabeth Holmes and Theranos issued marketing materials to future partner Walgreens that included the use of Pfizer’s corporate logo.

  October 25, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Colon Cancer Research: Testing, Studies and Future Outlook

  Colon cancer research has been making strides lately. Here’s everything you need to know.

  October 25, 2021

   · 

  3 min read

   · 

  Alina Zahid
• 

  Drug Development

  Scioto Hopes to Modify Autistic Behaviors by Improving the Gut Microbiome

  The concept is based on scientific studies showing that modulating the gut microbiome affects human health in multiple ways, beyond the expected gastrointestinal effects.

  October 25, 2021

   · 

  4 min read

   · 

  Gail Dutton
• 

  Drug Development

  Novartis Sees Glimmer of Hope in Phase III Lung Cancer Failure

  Novartis announced the CANOPY-1 Phase III trial of canakinumab failed to meet its primary endpoints when combined with Merck’s checkpoint inhibitor Keytruda (pembrolizumab).

  October 25, 2021

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  FDA Approves New Method for Macular Edema Treatment

  Xipere was approved for suprachoroidal use for the macular edema treatment. Macular edema is associated with uveitis, it is a form of eye inflammation.

  October 25, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Regeneron, Sanofi on a Roll as Dupixent Scores Second Consecutive Phase III Win

  Researchers found improvements in the study’s co-primary endpoints in patient-reported measures of esophageal inflammation and difficulty swallowing.

  October 25, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  FDA

  COVID Update: Pfizer-BioNTech Vaccine Effective in Kids, New Approaches and More

  The U.S. Food and Drug Administration posted analyses of the Pfizer-BioNTech COVID-19 vaccine in children ages 5 to 11 years old ahead of Tuesday’s vaccines advisory committee meeting.

  October 25, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  Janssen Scores Two Clinical Victories While ERYTECH Misses in Pancreatic Cancer

  Janssen reported analyses in which STELARA is showing promising results as a first-line therapy for Crohn’s Disease (CD) and Ulcerative Colitis (UC).

  October 25, 2021

   · 

  2 min read

   · 

  Kaylei Whalen
• 

  Business

  Feeling Collaborative, Merck Inks Three More Deals to Strengthen Portfolio

  Merck entered into collaborations with three different companies as it continues to assess Keytruda in combination with experimental drugs in different cancer indications.

  October 25, 2021

   · 

  4 min read

   · 

  Alex Keown
• 

  Drug Development

  Merck Sees Positive Signals for HIV Drug in Phase III

  The two Phase III studies are part of the ILLUMINATE clinical trial, which looks into the action of doravirine/islatravir (DOR/ISL) on HIV-1.

  October 25, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN